➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: September 24, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ENTOCORT EC

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Entocort Ec

Subscribe to access the full database, or Free Forever Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00135408 ↗	A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide	Completed	Medarex	Phase 2	2005-12-01	The purpose of the study is to determine Efficacy, Safety and Tolerability of MDX-010 (BMS-734016) administered with or without Prophylactic Oral Budesonide.
NCT00135408 ↗	A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide	Completed	Bristol-Myers Squibb	Phase 2	2005-12-01	The purpose of the study is to determine Efficacy, Safety and Tolerability of MDX-010 (BMS-734016) administered with or without Prophylactic Oral Budesonide.
NCT00343642 ↗	Dietary Treatment of Crohn's Disease	Completed	National Center for Complementary and Integrative Health (NCCIH)	Phase 1/Phase 2	2006-09-01	Our objective is to determine whether a specific dietary intervention or a fructooligosaccharide (FOS) supplement has anti-oxidant or prebiotic effects and whether it is beneficial in the treatment of Crohn's Disease (CD.
NCT00343642 ↗	Dietary Treatment of Crohn's Disease	Completed	Rush University Medical Center	Phase 1/Phase 2	2006-09-01	Our objective is to determine whether a specific dietary intervention or a fructooligosaccharide (FOS) supplement has anti-oxidant or prebiotic effects and whether it is beneficial in the treatment of Crohn's Disease (CD.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Entocort Ec

Condition Name

Chart
Table

Condition Name for Entocort Ec
Intervention	Trials
Crohn's Disease	4
Inflammatory Bowel Disease	2
Ulcerative Colitis	2
Stem Cell Transplantation	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Entocort Ec
Intervention	Trials
Crohn Disease	4
Ulcer	2
Colitis, Ulcerative	2
Colitis	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Entocort Ec

Trials by Country

Map
Table

Trials by Country for Entocort Ec
Location	Trials
United States	26
Canada	5
Poland	5
Italy	4
United Kingdom	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Entocort Ec
Location	Trials
New York	4
Illinois	3
Georgia	3
New Jersey	2
Minnesota	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Entocort Ec

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Entocort Ec
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	3
Phase 2	3
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Entocort Ec
Clinical Trial Phase	Trials
Completed	5
Terminated	3
Not yet recruiting	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Entocort Ec

Sponsor Name

Chart
Table

Sponsor Name for Entocort Ec
Sponsor	Trials
Perrigo Company	2
Pooja Budhiraja, MD	1
Valeant Pharmaceuticals International, Inc.	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Entocort Ec
Sponsor	Trials
Industry	7
Other	5
NIH	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon

Dow

AstraZeneca

Johnson and Johnson

Medtronic

Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.